WS
WST
Market ClosedWest Pharmaceutical Services, Inc.
US
10.80K employees
CEO: Michel Lagarde
Founded: 1980
$413.09
+$0.00(+NaN%)
Market Cap
28.78B
Beta
1.14
52W Range
N/A
Dividend Yield
0.21%
WST Price Chart
Historical price performance
Loading MCI price data...
MarketCI Investment Signals
AI-synthesized investment signal for WST built from valuation, fundamentals, sentiment, and risk models
Investment Signal
HoldPass %
57.14%
Score
4/7
Fair Value Estimate
Cash flow analysis • Multiple methods
$91.33
AI Price Target
Machine learning • Price prediction
$405.49
Market Sentiment
News & social media analysis
0.02
Value Investor Price
Classic value analysis
$42.44
Financial Health
Bankruptcy risk assessment
15.39
Quality Score
Financial strength rating
6.00
AI Investment Grade
Deep analysis of filings & news
75.00
Key Investment Highlights
Important factors affecting WST investment thesis
Due Diligence Analysis
Investment criteria assessment and scoring
Overall Assessment
55.26% Good
Conditions Met
21.00/38.00
Due Diligence Score
55.26%Due Diligence Conditions
Investment analysis conditions and results
Pass | |
Pass | |
Fail | |
Pass | |
Fail | |
Pass |
Showing 1 to 6 of 46 conditions
Latest News
Recent news and updates for WST
No recent news available for WST
Core Financials
Loading financial data for WST...
Explore WST
WST in the Healthcare
Large Cap